:: Library Catalog

Image de couverture de livre

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Qingsong Lai, Xiaohua Wang, Zebin Lai, Yulin Lai, Li Ye, Sha Liu, Bin Yang, Mao‐Qiang Man
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Journal of Diabetes
Accès en ligne:	https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.70022
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Cost‐effectiveness of continuous glucose monitoring in Chinese adults with uncontrolled type 2 diabetes: A modelling study stratified by baseline HbA 1c
par: Guangxin Han, et autres
Publié: (2025)

HbA1c ≤ 6.5% in Early Type 2 Diabetes: Threshold, Trajectory, or Marker of Integrated Risk Management?
par: Man Sun, et autres
Publié: (2026)

HbA1c and the Risk of Lower Limb Ulcers Among Diabetic Patients: An Observational and Genetics Study
par: Guojun Guo, et autres
Publié: (2025)

Baseline HbA1c and dementia risk at SGLT2i initiation in type 2 diabetes
par: Jiaqiang Zhang, et autres
Publié: (2025)

Incidence of treatment intensification based on HbA1c trends in people with type 2 diabetes
par: Erika Sugito, et autres
Publié: (2025)

The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes
par: Xiaopu Wang, et autres
Publié: (2024)

Associations of adipose tissue insulin resistance with fasting blood glucose and HbA1c in adults without diabetes
par: Ying Wei, et autres
Publié: (2026)

Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study
par: Yun‐Ru Lai, et autres
Publié: (2024)

Distribution of HbA1c Levels in Patients With GCK ‐ MODY : A Worldwide Literature‐Based Retrospective Analysis
par: Yihan Zhao, et autres
Publié: (2026)

Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE‐ O trial
par: Hertzel C. Gerstein, et autres
Publié: (2024)

Correction to “The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes”
Publié: (2025)

Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect HbA 1c reliability
par: Anxious J. Niwaha, et autres
Publié: (2025)

CGM ‐derived average glucose is more strongly associated with microvascular complications than HbA1c in type 1 diabetes
par: Roland H. Stimson, et autres
Publié: (2025)

Seasonal Variations in HbA1c and Body Composition: A Sex‐Specific Analysis in Adolescents With Type 1 Diabetes
par: Hussein Zaitoon, et autres
Publié: (2025)

The effect of sodium‐glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DM
par: Ran Guo, et autres
Publié: (2025)

Ketone test strip use is low in adults with type 1 diabetes and is not associated with HbA1c or glucose metrics on continuous glucose monitoring
par: Roland H. Stimson, et autres
Publié: (2026)

Importance of targeting post‐prandial hyperglycaemia to achieve HbA1c goals in insulin glargine‐treated subphenotypes of type 2 diabetes
par: Wolfgang Landgraf, et autres
Publié: (2025)

Healthcare Mistreatment and Cultural Beliefs Impact HbA1c in Patients with Type 2 Diabetes Mellitus
par: Hector Betancourt
Publié: (2019)

The Intermediate Glycemic Index: Filling the Temporal Gap Between Fructosamine and HbA1c
par: de Oliveira Andrade, Luís Jesuíno, et autres
Publié: (2026)

Pregnancy‐Specific Glucose Management Index Predicts Preterm Birth and Pre‐Eclampsia Superior to HbA1c in Women With Type 1 Diabetes Mellitus
par: Daizhi Yang, et autres
Publié: (2025)

Reassessment of the Diagnostic Accuracy of HbA 1c and Glucose for Type 2 Diabetes: A Systematic Review and Meta‐Analysis of Observational Studies
par: Christina Baechle, et autres
Publié: (2026)

Modification effect of receipt of diabetes care on the association between COVID‐19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population‐based database
par: Akira Okada, et autres
Publié: (2024)

Five‐year trajectories of HbA1c by age, sex, ethnicity and deprivation in adults with newly diagnosed type 2 diabetes: Observational study in England
par: Atanu Bhattacharjee, et autres
Publié: (2025)

Post‐load glucose is a stronger predictor of adverse pregnancy outcomes than first‐trimester HbA1c in women without gestational diabetes
par: Shahin Keshtkar Rajabi, et autres
Publié: (2024)

Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali: A randomised controlled trial
par: Stéphane Besançon, et autres
Publié: (2025)

Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c
par: Stephanie L. Samuels, et autres
Publié: (2024)

Predictors of glycaemic improvement in children and young adults with type 1 diabetes and very elevated HbA1c using the MiniMed 780G system
par: Yongwen Zhou, et autres
Publié: (2025)

Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial
par: Ying Zhu, et autres
Publié: (2025)

Changes in HbA1c and diabetes‐specific quality of life following structured type 1 diabetes education: Exploratory latent profile analysis of outcomes in the DAFNE plus trial
par: Uffe Søholm, et autres
Publié: (2026)

HbA 1c and the risk of developing peripheral neuropathy in childhood‐onset type 1 diabetes: A follow‐up study over 3 decades
par: Evangelia Baldimtsi, et autres
Publié: (2024)

Visit‐to‐visit HbA1c variability, risk of all‐cause mortality and diabetes‐related vascular complications among adult individuals with type 2 diabetes mellitus
par: Moses Yidong Lim, et autres
Publié: (2026)

Impact of automated insulin delivery on subjective and objective sleep in children and young adults with very high HbA1c : Sleep outcomes from the CO ‐ PILOT randomised controlled trial
par: Venus R. Michaels, et autres
Publié: (2025)

Impact of early and tight HbA1c control on the risk of long‐term complications and cardiovascular death in patients with type 2 diabetes from the Swedish National Diabetes Register
par: Julie Mount, et autres
Publié: (2026)

Interrelationship Between Baseline HbA1c , SGLT ‐2 Inhibitor Use and Risk of Diabetic Ketoacidosis in Adults With Type 2 Diabetes: A Systematic Review and Meta‐Analysis
par: Samuel Seidu, et autres
Publié: (2026)

Use of Freestyle Libre 2.0 in children with type 1 diabetes mellitus and elevated HbA1c: Extension phase results after a 12‐week randomized controlled trial
par: Yongwen Zhou, et autres
Publié: (2024)

Cardiovascular risk reduction with glucagon‐like peptide‐1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta‐regression analysis incorporating FLOW and SOUL trials
par: Masashi Hasebe, et autres
Publié: (2025)

Reply to Besançon et al. regarding ‘Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali: A randomised controlled trial’
par: Jennifer Manne‐Goehler, et autres
Publié: (2025)

‘There is more to life than HbA 1c ’: A comprehensive qualitative framework from the Hypo‐ RESOLVE project evidencing the impacts of hypoglycaemia on the quality of life of adults living with type 1 or type 2 diabetes
par: Philip A. Powell, et autres
Publié: (2026)

Commentary on “Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study”
par: Fatemeh Rasulpur, et autres
Publié: (2025)

La HbA1c en el diagnóstico y en el manejo de la diabetes
par: Germán Campuzano-Maya
Publié: (2010)